User:Mr. Ibrahem/Cenegermin

Cenegermin, sold under the brand name Oxervate, is a medication used to treat neurotrophic keratitis. It is used in those with moderate or severe disease. Use was not recommended by the United Kingdom. It is used as an eye drop.

Common side effects include eye pain, increased tear production, and eyelid pain. Safety in pregnancy is unclear. It is a recombinant form of nerve growth factor (NGF).

Cenegermin was approved for medical use in Europe in 2017 and the United States in 2018. In the United States 14 vials costs about 23,600 USD as of 2021.